Reduced levels of GP38 correlated with a high proportion of overall and CD4+ TILs, which contribute to tumor suppression (Zanetti, 2015), thus supporting an association between tumor immune status and overall survival in patients with BC. This evidence concerns the gene CD4 and breast cancer.